UCB SA (UCBJY)
OTCMKTS · Delayed Price · Currency is USD
149.68
+1.98 (1.34%)
Jan 7, 2026, 4:00 PM EST
UCB SA Market Cap
UCB SA has a market cap or net worth of $56.01 billion as of January 7, 2026. Its market cap has increased by 50.03% in one year.
Market Cap
56.01B
Enterprise Value
57.49B
Revenue
8.04B
Ranking
n/a
PE Ratio
35.81
Stock Price
$149.68
Market Cap Chart
Since April 5, 1995, UCB SA's market cap has increased from 1.20B to 56.01B, an increase of 4,564.96%. That is a compound annual growth rate of 13.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 6, 2026 | 56.01B | 5.23% |
| Dec 31, 2025 | 53.23B | 40.99% |
| Dec 31, 2024 | 37.75B | 128.16% |
| Dec 29, 2023 | 16.55B | 10.80% |
| Dec 30, 2022 | 14.93B | -30.70% |
| Dec 31, 2021 | 21.55B | 10.36% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 781.81M |
| Glass House Brands | 714.29M |
| Elite Pharmaceuticals | 516.25M |
| Northwest Biotherapeutics | 499.37M |
| Nika Pharmaceuticals | 395.17M |
| American Oncology Network | 394.40M |
| CytoDyn | 368.24M |
| Silence Therapeutics | 280.10M |